These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Author: Sun N, Chen X.
    Journal: Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459.
    Abstract:
    Polymerase chain reaction (PCR) of Epstein-Barr virus (EBV) EBNA-2 type A (PCR-A) along with dot blot hybridization using EBV DNA Bam-W and EBNA-2 type A and B fragment as the probes (DBH-W, -A, and -B) was performed in the nasopharyngeal biopsies. The positive rates of PCR-A, DBH-W, -A and -B were 83.9%, 80.6%, 74.2% and 0.0% in 31 cases of nasopharyngeal, respectively, and 12.0%, 40.0%, 92.0% and 0.0% in 25 cases of chronic nasopharyngitis (NP), respectively. There were significant differences between NPC and NP or non-NPC (P < = 0.0001) detected by PCR-A. The results indicated that positive PCR-A would be valuable for early diagnosis of nasopharyngeal carcinoma. The reasons which might make those differences were discussed.
    [Abstract] [Full Text] [Related] [New Search]